Functional Repair	1
the Corticospinal Tract	22
Delayed Transplantation	49
Olfactory Ensheathing Cells	76
Adult Rats Naghmeh Keyvan-Fouladi , Geoffrey Raisman ,	107
Adult Rats	107
Naghmeh Keyvan-Fouladi , Geoffrey Raisman ,	119
Naghmeh Keyvan-Fouladi	119
Geoffrey Raisman	143
Ying Li Division of Neurobiology	165
Ying Li Division	165
Neurobiology	185
Norman	199
Sadie Lee Research Centre	210
Medical Research Council	237
National Institute for Medical Research	263
National Institute	263
Medical Research	286
London , NW7 1AA , United Kingdom Adult rats	304
London	304
NW7 1AA , United Kingdom Adult rats	312
their forepaws	368
a piece of food	395
a piece	395
food	406
Destruction	412
the dorsal corticospinal tract	427
one side at the level of the first cervical segment	461
one side	461
the level of the first cervical segment	473
the level	473
the first cervical segment	486
the use of the ipsilateral forepaw for retrieval for at least 6 months	523
the use	523
the ipsilateral forepaw for retrieval for at least 6 months	534
the ipsilateral forepaw	534
retrieval for at least 6 months	562
retrieval	562
at least 6 months	576
operation	600
a variable amount of the corticospinal tract	617
a variable amount	617
the corticospinal tract	638
there	674
a proportionate persistence of retrieval	684
a proportionate persistence	684
retrieval	715
lesioned rats that had shown no retrieval for 8 weeks after operation	729
lesioned rats	729
no retrieval for 8 weeks	758
no retrieval	758
8 weeks	775
operation	789
a suspension of olfactory ensheathing cells	800
a suspension	800
olfactory ensheathing cells	816
the lesion site	862
1 and 3 weeks after transplantation	896
1 and 3 weeks	896
transplantation	916
all rats with transplants bridging the lesion site	933
all rats	933
transplants bridging the lesion site	947
transplants	947
the lesion site	968
retrieval	992
the ipsilateral forepaw	1005
Biotin dextran anterograde	1030
shows	1065
corticospinal axons	1084
the bridge	1113
≈ 10 mm in the distal part of the corticospinal tract	1148
≈ 10 mm	1148
the distal part of the corticospinal tract	1157
the distal part	1157
the corticospinal tract	1176
terminal arborizations	1212
the spinal gray matter	1238
Functional recovery	1262
only ≈ 1 % of the corticospinal tract axons	1297
only ≈ 1 %	1297
only ≈	1297
the corticospinal tract axons	1309
Introduction	1353
We	1366
unilateral lesions of the dorsal corticospinal tract -LRB- CST -RRB-	1399
unilateral lesions	1399
the dorsal corticospinal tract -LRB- CST -RRB-	1421
the dorsal corticospinal tract	1421
CST	1453
forepaw retrieval -LRB- DFR -RRB-	1475
forepaw retrieval	1475
DFR	1494
the ipsilateral forepaw -LRB- Li et al. , 1997 -RRB-	1502
the ipsilateral forepaw	1502
Li	1527
et al. , 1997	1530
et al.	1530
1997	1538
Olfactory ensheathing cells -LRB- OECs -RRB-	1545
Olfactory ensheathing cells	1545
OECs	1574
the lesion site	1598
the time of injury	1617
the time	1617
injury	1629
a recovery of DFR	1644
a recovery	1644
DFR	1658
The potential value of such an approach to human spinal cord injuries	1663
The potential value	1663
such an approach to human spinal cord injuries	1686
such an approach	1686
human spinal cord injuries	1706
account	1756
the inevitable delay	1764
clinical practice between the time of injury	1804
clinical practice	1804
the time of injury	1830
the time	1830
injury	1842
the time when the patient is sufficiently stable	1853
the time	1853
the patient	1867
no further spontaneous recovery	1922
transplantation	1978
most previous studies of repair	1998
most previous studies	1998
repair	2023
transplantation	2031
the same time	2064
the lesions	2078
Imaizumi et al. , 1998 ; Ramo ' n-Cueto et al. , 1998 , 2000	2101
Imaizumi et al.	2101
Imaizumi	2101
et al.	2110
1998 ; Ramo ' n-Cueto et al.	2118
1998	2118
Ramo ' n-Cueto et al.	2124
Ramo ' n-Cueto	2124
Ramo '	2124
et al.	2138
1998 , 2000	2146
1998	2146
2000	2152
functional improvement	2174
delayed transplantation	2221
fetal spinal cord	2248
cerebral tissue	2267
adult peripheral nerve tissue	2288
Coumans	2319
et al. , 2001 ; Zurita et al. , 2001	2327
et al.	2327
2001 ; Zurita et al.	2335
2001	2335
Zurita et al.	2341
Zurita	2341
et al.	2348
2001	2356
chronic rat spinal cord lesions	2367
Lu et al. -LRB- 2002 -RRB- and Plant et al. -LRB- 2003 -RRB-	2400
Lu et al. -LRB- 2002 -RRB-	2400
Lu	2400
et al. -LRB- 2002 -RRB-	2403
et al.	2403
2002	2411
Plant et al. -LRB- 2003 -RRB-	2421
Plant	2421
et al. -LRB- 2003 -RRB-	2427
et al.	2427
2003	2435
an improvement of locomotor function	2455
an improvement	2455
locomotor function	2473
delayed transplantation	2498
OECs into complete or incomplete thoracic spinal lesions	2525
OECs	2525
complete or incomplete thoracic spinal lesions	2535
the present study	2586
we	2605
OECs	2628
DFR	2659
transplantation	2668
2 months	2699
complete unilateral destruction of the CST	2714
complete unilateral destruction	2714
the CST	2749
Materials and Methods Pretraining .	2759
Materials and Methods	2759
Materials	2759
Methods	2773
3 successive days before operation	2797
3 successive days	2797
operation	2822
adult	2833
body	2840
weight , 200 -- 240 gm	2845
weight	2845
200	2853
240 gm	2857
female rats of a locally inbred Albino Swiss strain	2865
female rats	2865
a locally inbred Albino Swiss strain	2880
the testing cage	2936
a piece of food	2954
a piece	2954
food	2965
a slit in the front of the cage , and the number of times the right	2992
a slit	2992
the front of the cage , and the number of times the right	3002
the front of the cage	3002
the front	3002
the cage	3015
the number of times the right	3029
the number of times	3029
the number	3029
times	3043
the right	3049
paws	3068
an overall total of 50 retrievals	3100
an overall total	3100
50 retrievals	3120
The majority of rats	3135
The majority	3135
rats	3151
10 % of rats	3202
10 %	3202
rats	3209
an asymmetry of use	3221
an asymmetry	3221
use	3237
15/35	3242
these	3253
Lesion .	3282
we	3298
the functional effect of unilateral lesions of the CST	3317
the functional effect	3317
unilateral lesions of the CST	3342
unilateral lesions	3342
the CST	3364
involvement of other tracts in the dorsal columns	3383
involvement	3383
other tracts in the dorsal columns	3398
other tracts	3398
the dorsal columns	3414
avoiding damage to the lateral columns	3445
avoiding damage	3445
the lateral columns	3464
we	3485
a stereotaxic approach	3493
we	3525
the lesion size and position	3554
the CST	3586
Anesthetized rats -LRB- n = 54 -RRB-	3595
Anesthetized rats	3595
n	3614
54	3616
a stereotaxic frame	3636
the neck	3662
the dorsal surface of the spinal cord	3679
the dorsal surface	3679
the spinal cord	3701
the level of the first	3732
the level	3732
the first	3745
second cervical segments	3758
a midline incision	3791
A stainless steel electrode	3811
250 µm diameter	3842
1 mm of the tip	3879
1 mm	3879
the tip	3887
a depth of 1 mm at a point 500µm lateral	3912
a depth	3912
1 mm at a point 500µm lateral	3923
1 mm	3923
a point 500µm lateral	3931
the midline	3956
The identification of the midline	3969
The identification	3969
the midline	3991
the presence of the median sagittal vein	4021
the presence	4021
the median sagittal vein	4037
this	4072
some variation in electrode placement	4118
some variation	4118
electrode placement	4136
Approximately equal numbers of rats	4157
Approximately equal numbers	4157
rats	4188
the right	4210
sides	4229
The CST	4236
a heat lesion	4261
a radiofrequency lesion device	4287
RFG-3C RF ; Radionics Inc. , Burlington , MA	4319
RFG-3C RF	4319
Radionics Inc. , Burlington , MA	4330
10 V for 1 min	4375
10 V	4375
1 min	4384
This	4391
ovoid lesions of 0.5 -- 1.0 mm in diameter	4419
ovoid lesions of 0.5	4419
ovoid lesions	4419
0.5	4436
1.0 mm in diameter	4440
1.0 mm	4440
diameter	4449
the size of the lesions -LRB- 0.5 -- 1.0 mm -RRB-	4467
the size	4467
the lesions -LRB- 0.5 -- 1.0 mm -RRB-	4479
the lesions	4479
0.5 -- 1.0 mm	4492
0.5	4492
1.0 mm	4496
that of the target CST -LRB- 0.5 mm -RRB-	4530
that	4530
the target CST -LRB- 0.5 mm -RRB-	4538
the target CST	4538
0.5 mm	4554
slight errors in electrode placement	4563
slight errors	4563
electrode placement	4580
sparing of varying amounts of the target	4607
sparing	4607
varying amounts of the target	4618
varying amounts	4618
the target	4637
Postoperative testing .	4649
Three days	4672
operation	4689
the rats	4700
the testing cage and the use of the right	4728
the testing cage	4728
the use of the right	4749
the use	4749
the right	4760
paws	4779
50 retrievals three times per week for 8 successive weeks	4799
50 retrievals	4799
three times	4813
week for 8 successive weeks	4829
week	4829
8 successive weeks	4838
21 rats	4861
either retention of ipsilateral DFR or a loss of DFR	4881
retention of ipsilateral DFR	4888
retention	4888
ipsilateral DFR	4901
a loss of DFR	4920
a loss	4920
DFR	4930
a progressive return	4947
subsequent histology	4969
all cases	5005
the lesions of the CST	5015
the lesions	5015
the CST	5030
This series of incomplete lesions	5055
This series	5055
incomplete lesions	5070
the correlation between lesion size and DFR	5107
the correlation	5107
lesion size and DFR	5131
33 rats	5155
the ipsilateral forepaw for retrieval	5180
the ipsilateral forepaw	5180
retrieval	5208
the 8 weeks of postlesion testing	5222
the 8 weeks	5222
postlesion testing	5237
7	5257
the completeness of the lesions	5276
the completeness	5276
the lesions	5296
calcium calmodulin kinase II -LRB- CaM-II -RRB- immunostaining	5324
the remaining 26 rats	5393
12	5416
transplants of OECs	5428
transplants	5428
OECs	5443
2	5464
injections of OEC-conditioned medium -LRB- as a control -RRB-	5475
injections	5475
OEC-conditioned medium -LRB- as a control -RRB-	5489
OEC-conditioned medium	5489
a control	5516
These rats	5528
three times per week	5551
three times	5551
week	5567
an additional 8 weeks	5576
the remaining 12 lesioned rats	5602
the remaining	5602
12 lesioned rats	5616
transplants	5642
six	5656
once a week	5672
an additional 16 weeks	5688
a total of 24 weeks	5715
a total	5715
24 weeks	5726
Cell culture .	5737
Cell	5737
culture	5742
Tissue	5751
the outer nerve and glomerular layers of the rat olfactory bulb	5777
the outer nerve	5777
glomerular layers of the rat olfactory bulb	5797
glomerular layers	5797
the rat olfactory bulb	5818
0.1 % trypsin for 15 min at 37 °C	5855
0.1 % trypsin	5855
15 min at 37 °C	5872
15 min	5872
37 °C	5882
35mmdishes coated with poly-L-lysine	5901
35mmdishes	5901
poly-L-lysine	5924
14 -- 17 d in DMEM -- F-12 medium	5956
14 -- 17 d in DMEM --	5956
14	5956
17 d in DMEM	5959
17 d	5959
DMEM	5967
10 % FCS -LRB- 3133-028 ; Invitrogen , Paisley , UK -RRB-	5994
10 % FCS	5994
3133-028 ; Invitrogen , Paisley , UK	6003
3133-028	6003
Invitrogen , Paisley , UK	6013
Each dish	6039
1 million cells , of which 50 % were p75-positive	6058
1 million cells	6058
50 %	6085
Schwann-like OECs and 50 %	6108
Schwann-like OECs	6108
50 %	6130
fibronectin	6139
FN	6152
positive olfactory nerve fibroblasts -LRB- Li et al. , 1998 -RRB-	6156
positive olfactory nerve fibroblasts	6156
Li	6194
et al. , 1998	6197
et al.	6197
1998	6205
Fourteen rats that had shown complete absence of DFR for 8 weeks after lesion	6229
Fourteen rats	6229
complete absence of DFR	6258
complete absence	6258
DFR	6278
8 weeks	6286
lesion	6300
the spinal cord	6332
the same	6369
the lesioning	6397
a solenoidcontrolled air pressure device	6412
5 µl	6462
a suspension of 25 x 106/ml OECs -LRB- n = 12 -RRB-	6470
a suspension of 25	6470
a suspension	6470
25	6486
106/ml OECs -LRB- n = 12 -RRB-	6491
106/ml OECs	6491
n	6504
12	6508
OEC-conditioned medium -LRB- n = 2 -RRB-	6515
OEC-conditioned medium	6515
n	6539
2	6543
a glass micropipette -LRB- 100 -- 150 µm tip -RRB-	6550
a glass micropipette	6550
100 -- 150 µm tip	6572
100	6572
150 µm tip	6576
the lesion site -LRB- Li et al. , 1997 -RRB-	6593
the lesion site	6593
Li	6610
et al. , 1997	6613
et al.	6613
1997	6621
Axon tracing .	6628
Axon	6628
Four rats with transplants and six rats with lesion	6642
Four rats	6642
transplants and six rats with lesion	6657
transplants	6657
six rats with lesion	6673
six rats	6673
lesion	6687
CST axons	6722
A total	6733
10 % biotin dextran -LRB- BD -RRB-	6744
10 % biotin dextran	6744
BD	6764
0.5 µl ; molecular weight , 10,000 ; Molecular Probes , Eugene , OR	6769
0.5 µl	6769
molecular weight , 10,000 ; Molecular Probes , Eugene , OR	6777
molecular weight , 10,000	6777
molecular weight	6777
10,000	6795
Molecular Probes , Eugene , OR	6803
Molecular Probes	6803
Eugene	6821
OR	6829
Brandt and Apkarian	6834
1992	6855
saline	6864
anesthesia	6906
a 100 µm tip glass micropipette	6925
each of the four points	6960
each	6960
the four points	6968
the mediolateral extent	6990
the contralateral sensorimotor cortex -LRB- Li et al. , 1998 -RRB-	7017
the contralateral sensorimotor cortex	7017
Li	7056
et al. , 1998	7059
et al.	7059
1998	7067
2 weeks	7073
4 % paraformaldehyde	7103
Histology	7124
immunostaining on semithin sections	7139
immunostaining	7139
semithin sections	7157
rats	7176
deep terminal anesthesia	7201
a mixture of 1 % paraformaldehyde and 1 % glutaraldehyde	7231
a mixture	7231
1 % paraformaldehyde and 1 % glutaraldehyde	7244
1 % paraformaldehyde	7244
1 % glutaraldehyde	7268
0.1 M PBS	7289
resin	7315
Coronal sections -LRB- 1 -- 2 µm -RRB-	7322
Coronal sections	7322
1 -- 2 µm	7340
1	7340
2 µm	7342
the lesion/transplant site	7365
ethanolic sodium hydroxide for 9 min for resin etching	7406
ethanolic sodium hydroxide	7406
9 min for resin etching	7437
9 min	7437
resin etching	7447
a slide	7483
1:1000	7496
anti-FN -LRB- Invitrogen -RRB-	7503
1:3000 P0 antiserum	7527
a gift from J. J. Archelos	7548
a gift	7548
J. J. Archelos	7560
Max-Planck Institute , Munich , Germany	7576
Max-Planck Institute	7576
Munich , Germany	7598
The reaction product	7616
diaminobenzidine	7657
the sections	7679
methylene blue and Azur II	7717
methylene blue	7717
Azur II	7736
BD labeling	7749
rats	7762
4 % paraformaldehyde	7786
60 m	7810
horizontal cryostat sections	7816
the lesion/transplant area	7862
ABC -LRB- Vector Laboratories , Peterborough , UK -RRB-	7906
ABC	7906
Vector Laboratories	7911
Peterborough	7932
UK	7946
overnight	7950
BD	7961
1:200 Strep Avidin-green -LRB- Alexa Fluor 438 ; Molecular Probes -RRB- in PBS	7982
1:200 Strep Avidin-green -LRB- Alexa Fluor 438 ; Molecular Probes -RRB-	7982
1:200 Strep Avidin-green	7982
Alexa Fluor 438 ; Molecular Probes	8008
Alexa Fluor 438	8008
Molecular Probes	8025
PBS	8046
2 hr at room temperature	8054
2 hr	8054
room temperature	8062
PBS	8090
propidium iodide for confocal microscopy	8119
propidium iodide	8119
confocal microscopy	8140
the transplanted cells and monitor cell migration	8173
the transplanted cells	8173
monitor cell migration	8200
rats	8224
PBS	8248
10 µm	8256
horizontal cryostat sections	8262
FN	8314
0.5 % aqueous neutral red	8352
the completeness of the lesions	8393
the completeness	8393
the lesions	8413
10 µm coronal cryostat sections	8426
10 µm	8426
1:500 CaM-II -LRB- Zymed , San Francisco , CA -RRB-	8482
Zymed	8496
San Francisco	8503
CA	8518
Terashima	8523
et al. , 1994	8533
et al.	8533
1994	8541
0.5 % aqueous neutral red	8571
Photomicrographs at 10x	8597
Photomicrographs	8597
10x	8617
three adjacent sections at 1mmcaudal	8635
three adjacent sections	8635
1mmcaudal	8662
the lesion	8675
The extent of the lesions	8703
The extent	8703
the lesions	8717
a percentage	8746
the area	8762
the unoperated side -LRB- an average of the three sections -RRB-	8774
the unoperated side	8774
an average of the three sections	8795
an average	8795
the three sections	8809
a 5 mm	8850
grid	8865
the CST	8875
Results Lesions	8885
transplants	8909
The CST	8921
methylene blue/Azur II-stained semithin sections -LRB- Fig. 1A -RRB-	8950
methylene blue/Azur II-stained semithin sections	8950
methylene blue/Azur	8950
II-stained semithin sections	8970
Fig. 1A	9000
The corticospinal axons	9010
anterograde BD labeling in serial horizontal sections -LRB- Fig. 1C -RRB-	9056
anterograde BD labeling	9056
serial horizontal sections -LRB- Fig. 1C -RRB-	9083
serial horizontal sections	9083
Fig. 1C	9111
CaM-II immunohistochemistry in cross-sections -LRB- Fig. 2A -RRB-	9124
CaM-II immunohistochemistry	9124
cross-sections -LRB- Fig. 2A -RRB-	9155
cross-sections	9155
Fig. 2A	9171
the top cervical level	9184
the CST	9208
0.5 mm	9220
diameter	9230
The electrode	9240
lesions of ≈ 0.5 -- 1.0 mmin diameter on one side	9263
lesions	9263
≈ 0.5 -- 1.0 mmin diameter on one side	9274
≈ 0.5	9274
1.0 mmin diameter on one side	9279
1.0 mmin diameter	9279
one side	9299
semithin sections	9312
the lesions	9331
fluid-filled cavities	9348
macrophages and tissue debris but	9381
macrophages and tissue debris	9381
neither axons nor glia -LRB- Fig. 1A , B -RRB-	9415
axons	9423
glia -LRB- Fig. 1A , B -RRB-	9433
glia	9433
Fig. 1A , B	9439
Fig. 1A	9439
B	9447
The unavoidable minor variations in electrode positioning	9451
The unavoidable minor variations	9451
electrode positioning	9487
varying degrees of destruction of the CST -LRB- see Materials and Methods -RRB-	9521
varying degrees	9521
destruction of the CST -LRB- see Materials and Methods -RRB-	9540
destruction	9540
the CST	9555
Materials and Methods	9568
Materials	9568
Methods	9582
The extent of the lesions	9592
The extent	9592
the lesions	9606
semithin sections	9640
anterograde BD labeling -LRB- Fig. 1C -RRB-	9662
anterograde BD labeling	9662
Fig. 1C	9687
a complete series	9699
contiguous horizontal sections through the entire width of the tract	9720
contiguous horizontal sections	9720
the entire width of the tract	9759
the entire width	9759
the tract	9779
CaM-II staining in the tract 1 mm caudal to the lesion -LRB- Fig. 2F -RRB-	9796
CaM-II staining	9796
the tract 1 mm caudal to the lesion -LRB- Fig. 2F -RRB-	9815
the tract 1 mm caudal	9815
the lesion -LRB- Fig. 2F -RRB-	9840
the lesion	9840
Fig. 2F	9852
the case of incomplete lesions	9865
the case	9865
incomplete lesions	9877
the degree of destruction of the CST	9897
the degree	9897
destruction of the CST	9911
destruction	9911
the CST	9926
the area of remaining CaM-II staining -LRB- Fig. 2 -RRB-	9951
the area	9951
remaining CaM-II staining -LRB- Fig. 2 -RRB-	9963
remaining CaM-II staining	9963
Fig. 2	9990
Functional effect of lesions Rats with no functional recovery	9999
Functional effect	9999
lesions Rats with no functional recovery	10020
lesions Rats	10020
no functional recovery	10038
There	10061
19 rats	10072
the ipsilateral forepaw	10096
retrieval at any time	10124
retrieval	10124
any time	10137
the postoperative period	10153
8 weeks -LRB- n = 7 ; Fig. 3A , OE -RRB- or 24 weeks -LRB- n = 6 -RRB-	10181
8 weeks -LRB- n = 7 ; Fig. 3A , OE -RRB-	10181
n = 7 ; Fig. 3A , OE	10190
n	10190
= 7 ; Fig. 3A , OE	10192
= 7	10192
Fig. 3A , OE	10197
Fig. 3A	10197
OE	10206
24 weeks -LRB- n = 6 -RRB-	10213
n	10223
6	10227
the six cases with semithin histology	10234
the six cases	10234
semithin histology	10253
there	10273
a cyst	10283
the entire position of the CST	10304
the entire position	10304
the CST	10327
no detectable remnants of the tract on the lesioned side	10344
no detectable remnants	10344
the tract on the lesioned side	10370
the tract	10370
the lesioned side	10383
the seven cases with CaM-II staining	10405
the seven cases	10405
CaM-II staining	10426
there	10443
no visible staining in the distal tract	10453
no visible staining	10453
the distal tract	10476
the six cases with BD	10497
the six cases	10497
BD	10516
no fibers	10528
the lesion area	10555
the distal tract	10577
response to food presentation	10598
response	10598
food presentation	10610
it	10629
these rats	10647
the ipsilateral forepaw	10675
repeated shortrange distal grasping movements	10708
wrist supination and digit flexion	10755
wrist supination	10755
digit flexion	10776
response	10809
food presentation	10821
they	10844
retrieval	10869
the animals	10887
the proximal arm and shoulder muscles	10911
the directed movement of extending their arms through the slit	10960
the directed movement	10960
their arms	10995
the slit	11014
the grasp	11031
range of the food	11060
range	11060
the food	11069
the contralateral forepaw	11089
the rats	11131
retrieval	11163
the ipsilateral forepaw	11178
the food	11236
the tongue or snout	11250
the defect in retrieval	11282
the defect	11282
retrieval	11296
we	11307
no impairment	11316
the ipsilateral forepaw	11333
other functions	11360
a cage edge	11399
food	11460
no asymmetry	11486
Rats with functional recovery	11500
Rats	11500
functional recovery	11510
There	11530
21 rats that retained a degree of DFR by the ipsilateral forepaw	11541
21 rats	11541
a degree of DFR	11563
a degree	11563
DFR	11575
the ipsilateral forepaw	11582
Subsequent histology	11607
each	11640
a degree of sparing of the CST fibers	11649
a degree	11649
sparing of the CST fibers	11661
sparing	11661
the CST fibers	11672
the presence of CaM-II immunostaining	11703
the presence	11703
CaM-II immunostaining	11719
the distal CST 1 mm caudal to the lesion	11744
the distal CST 1 mm caudal	11744
the lesion	11774
the three groups	11789
rats with the smaller lesions	11809
rats	11809
the smaller lesions	11819
60 % of the tract	11857
60 %	11857
the tract	11864
the ipsilateral forepaw	11876
the first time	11914
a reduced level	11944
normal levels	12012
8 weeks	12029
The two groups of rats with the larger lesions	12038
The two groups	12038
rats with the larger lesions	12056
rats	12056
the larger lesions	12066
60 %	12098
the tract	12105
retrieval	12130
the second postoperative week	12146
8 weeks	12212
the rising curve	12230
greater recovery	12262
longer survivals	12307
Lesions sparing only ≈ 1 % of the CST axons	12325
Lesions	12325
1 %	12347
the CST axons	12353
Fig. 2G , H	12368
Fig. 2G	12368
H	12376
a case with ≈ 400 axons	12379
a case with ≈	12379
a case	12379
≈	12391
400 axons	12392
spontaneous return of DFR	12430
spontaneous return	12430
DFR	12452
a delay of 3 weeks	12472
a delay	12472
3 weeks	12483
The data in Figure 3A	12492
The data	12492
Figure 3A	12504
bins of 1	12531
bins	12531
1	12539
19 % -LRB- n = 4 rats -RRB- , 20	12541
19 %	12541
n	12546
4 rats	12550
20	12559
39 % -LRB- n = 4 -RRB- , 40	12562
39 %	12562
n	12567
4	12571
40	12575
59 % -LRB- n = 4 -RRB- , 60	12578
59 %	12578
n	12583
4	12587
60	12591
79 % -LRB- n = 5 -RRB- , 80	12594
79 %	12594
n	12599
5	12603
80	12607
99 % -LRB- n = 4 -RRB-	12610
99 %	12610
n	12615
4	12619
100 % -LRB- n = 7 -RRB-	12627
100 %	12627
n	12633
7	12637
a whole	12650
the total number of retrievals by the ipsilateral forepaw	12659
the total number	12659
retrievals by the ipsilateral forepaw	12679
retrievals	12679
the ipsilateral forepaw	12693
r = 0.95	12741
r	12741
= 0.95	12743
the percentage	12756
surviving axons -LRB- Fig. 3B -RRB-	12774
surviving axons	12774
Fig. 3B	12791
Transplants Function Transplantations	12801
an additional group	12857
14 rats in which there had been no recovery of DFR for 8 weeks after lesion	12880
14 rats	12880
there	12897
no recovery of DFR for 8 weeks	12912
no recovery	12912
DFR for 8 weeks	12927
DFR	12927
8 weeks	12935
lesion	12949
these	12960
12	12967
transplants of OECs and 2	12979
transplants	12979
OECs and 2	12994
OECs	12994
2	13003
control injections of OEC-conditioned medium	13014
control injections	13014
OEC-conditioned medium	13036
All 14 rats	13060
DFR three times per week for 8 weeks	13093
DFR	13093
three times	13097
week for 8 weeks	13113
week	13113
8 weeks	13122
the transplantation	13136
these	13160
10	13167
a return	13177
DFR	13189
1	13209
3 weeks after transplantation	13211
3 weeks	13211
transplantation	13225
some additional increase	13261
up to 8 weeks	13286
transplantation	13306
Fig. 4	13323
Subsequent histology -LRB- see below -RRB-	13332
Subsequent histology	13332
all 10 of these rats	13375
all 10	13375
these rats	13385
the CST	13401
the lesion site	13443
transplanted OECs -LRB- Fig. 5A -RRB-	13482
transplanted OECs	13482
Fig. 5A	13501
the recovery	13516
function	13532
this long lesion plus transplant survival period -LRB- 16 weeks -RRB-	13547
this long lesion	13547
transplant survival period	13569
16 weeks	13597
the longer overall survival period -LRB- of 8 + 16 = 24 weeks -RRB-	13638
the longer overall survival period	13638
8 + 16 = 24 weeks	13677
8	13677
16 = 24 weeks	13681
the prolonged testing	13699
the failure	13740
return	13755
DFR	13765
six untransplanted rats	13772
24 weeks	13799
complete lesions	13814
Two of the transplanted rats	13844
Two	13844
the transplanted rats	13851
no return of DFR	13880
no return	13880
DFR	13893
the 8 weeks	13902
transplantation	13920
these rats	13940
subsequent histology	13952
the transplants	13985
the ascending dorsal columns	14033
the lesioned CST -LRB- Fig. 5B -RRB-	14082
the lesioned CST	14082
Fig. 5B	14100
The two rats with control injections of OECconditioned medium	14110
The two rats	14110
control injections of OECconditioned medium	14128
control injections	14128
OECconditioned medium	14150
no return of DFR	14184
no return	14184
DFR	14197
the 8 weeks	14206
injection	14224
the histology in all four of these cases	14239
the histology	14239
all four of these cases	14256
all four	14256
these cases	14268
the lesions	14295
the CST	14332
Histology FN staining of the olfactory nerve fibroblasts	14341
Histology FN staining	14341
the olfactory nerve fibroblasts	14366
the transplants	14406
solid , highly vascularized tissue masses	14450
0.5 mm	14493
transverse diameter	14503
1.0 mm in the dorsoventral direction -LRB- Fig. 5A -RRB-	14541
1.0 mm	14541
the dorsoventral direction -LRB- Fig. 5A -RRB-	14551
the dorsoventral direction	14551
Fig. 5A	14579
the 10 rats in which the transplants were located in the CST	14592
the 10 rats	14592
the transplants	14613
the CST	14645
the transplanted cells	14654
the former lesion cavity	14684
up to 7 mm in the distal part of the CST -LRB- Fig. 6A -RRB-	14735
up to 7 mm	14735
the distal part of the CST -LRB- Fig. 6A -RRB-	14749
the distal part	14749
the CST -LRB- Fig. 6A -RRB-	14768
the CST	14768
Fig. 6A	14777
p75 immunostaining	14787
the Schwann-like OECs	14839
culture	14864
short-term survivals	14879
transplantation	14906
the present material	14942
it	14971
≈ 3 weeks	14997
the presence of the Schwann-like OECs	15016
the presence	15016
the Schwann-like OECs	15032
P0 immunostaining for peripheral myelin -LRB- Fig. 7 ;	15077
P0 immunostaining	15077
peripheral myelin -LRB- Fig. 7 ;	15099
peripheral myelin	15099
Fig. 7	15118
BD anterograde	15138
data in four rats	15161
data	15161
four rats	15169
transplanted OECs and post transplantation return of DFR	15184
transplanted OECs	15184
post transplantation return of DFR	15206
post transplantation return	15206
DFR	15237
BD-labeled CST axons	15248
the transplants	15293
the le - sion/transplant site	15325
le	15329
sion/transplant site	15333
the BD-labeled axons	15355
primarily unbranched fibers	15399
11mmthrough the caudal part of the CST	15435
11mmthrough the caudal part	15435
the CST	15466
collateral branches	15484
right angles	15517
a lateral direction	15562
the adjacent gray matter	15587
they	15619
arborizations -LRB- Fig. 6B -- D -RRB-	15638
arborizations	15638
Fig. 6B -- D	15653
Fig. 6B	15653
D	15661
10 rats studied in cross-section histology	15668
10 rats	15668
cross-section histology	15687
P0 immunohistochemistry for peripheral myelin	15712
P0 immunohistochemistry	15712
peripheral myelin	15740
the axons passing through the transplants	15778
the axons	15778
the transplants	15804
OECs -LRB- Fig. 7 -RRB-	15839
OECs	15839
Fig. 7	15845
The P0 staining in cross-section	15854
The P0 staining	15854
cross-section	15873
us	15895
the total number of fibers crossing the transplants -LRB- Fig. 7B , C -RRB-	15907
the total number	15907
fibers crossing the transplants -LRB- Fig. 7B , C -RRB-	15927
fibers	15927
the transplants -LRB- Fig. 7B , C -RRB-	15943
the transplants	15943
Fig. 7B , C	15960
Fig. 7B	15960
C	15968
seven rats	15976
the mean and SE	15988
526	16008
58	16014
Discussion	16019
repair	16038
a necessity in any future clinical trials	16053
a necessity	16053
any future clinical trials	16068
the unpredictability of `` spontaneous '' repair	16112
the unpredictability	16112
`` spontaneous '' repair	16136
the prognosis for any individual spinal-injured patient	16163
the prognosis	16163
any individual spinal-injured patient	16181
up to 1 year	16240
injury	16259
the present study	16270
we	16289
a model of a delayed transplantation para - digm	16318
a model	16318
a delayed transplantation para - digm	16329
a delayed transplantation para	16329
digm	16361
The most important conclusion of the present observations	16367
The most important conclusion	16367
the present observations	16400
the previously reported reparative effect	16433
immediate transplantation OECs	16478
DFR -LRB- Li et al. , 1997 -RRB-	16512
DFR	16512
Li	16517
et al. , 1997	16520
et al.	16520
1997	16528
the transplantation	16561
8 weeks	16596
the lesion	16610
The effect of CST lesions on DFR The present results	16622
The effect	16622
CST lesions on DFR The present results	16636
CST lesions	16636
DFR The present results	16651
DFR	16651
The present results	16655
DFR	16689
at least 6 months	16710
unilateral destruction of the rat dorsal CST	16734
unilateral destruction	16734
the rat dorsal CST	16760
the top cervical level	16782
This loss of DFR	16806
This loss	16806
DFR	16819
either paralysis or any obvious weakness	16846
paralysis	16853
any obvious weakness	16866
the affected forepaw	16890
motivation	16922
retrieval movements of the affected forepaw	16969
retrieval movements	16969
the affected forepaw	16992
they	17040
The failure	17059
the ability of the proximal musculature	17086
the ability	17086
the proximal musculature	17101
the forelimb	17136
the slit and place	17157
it	17176
a position	17182
the wrist flexors	17202
the paw	17243
contact with the food pellet	17256
contact	17256
the food pellet	17269
There	17286
no obvious asymmetry	17295
the use of the forelimbs	17319
the use	17319
the forelimbs	17330
the food	17381
it	17395
The selective sensitivity of the proximal muscles to CST lesions	17416
The selective sensitivity	17416
the proximal muscles to CST lesions	17445
the proximal muscles	17445
CST lesions	17469
an anatomical and electrophysiological study	17491
Ku ¨ chler et al. , 2002	17537
Ku ¨ chler	17537
et al.	17546
2002	17554
contrast to the CST	17581
contrast	17581
the CST	17593
the rubrospinal tract	17602
a monosynaptic projection	17628
the somata	17657
major dendrites	17672
the cervical motoneurons innervating the distal forelimb muscles	17691
the cervical motoneurons	17691
the distal forelimb muscles	17728
a less direct influence over the more proximal muscles	17764
a less direct influence	17764
the more proximal muscles	17793
A complex coordinated movement such as DFR	17820
A complex coordinated movement	17820
DFR	17859
all the other necessary adjustments of body	17878
all the other necessary adjustments	17878
body	17917
position , balance , and posture	17922
the arm and paw retrieval	17968
activity of many supraspinal and intraspinal pathways	18014
activity	18014
many supraspinal and intraspinal pathways	18026
a number of different ascending and descending spinal tracts	18078
a number	18078
different ascending and descending spinal tracts	18090
different	18090
spinal tracts	18125
components	18160
the overall performance	18174
DFR -LRB- McKenna and Whishaw , 1999 ; Weidner et al. , 2001 -RRB-	18201
DFR	18201
McKenna and Whishaw , 1999 ; Weidner et al. , 2001	18206
McKenna and Whishaw	18206
1999 ; Weidner et al.	18227
1999	18227
Weidner et al.	18233
Weidner	18233
et al.	18241
2001	18249
our present use of small circumscribed lesions	18256
our present use	18256
small circumscribed lesions	18275
our previous finding	18312
severance	18338
the dorsal CST	18351
other tracts	18387
the rubrospinal tract -LRB- in the lateral columns -RRB-	18409
the rubrospinal tract	18409
the lateral columns	18435
the ventral CST -LRB- in the ventral columns -RRB-	18459
the ventral CST	18459
the ventral columns	18479
variable damage to the ascending -LRB- sensory -RRB- dorsal columns nevertheless	18532
variable damage	18532
the ascending -LRB- sensory -RRB- dorsal columns nevertheless	18551
the	18551
sensory	18566
dorsal columns	18575
ipsilateral DFR	18624
there	18645
no return of this function for up to 6 months	18654
no return	18654
this function for up to 6 months	18667
this function	18667
up to 6 months	18685
partial spinal cord lesions	18707
it	18736
both animal and human studies	18753
both animal	18753
human studies	18769
major functional recovery	18788
the absence of regeneration of the severed connections	18827
the absence	18827
regeneration of the severed connections	18842
regeneration	18842
the severed connections	18858
The mechanism of this recovery	18883
The mechanism	18883
this recovery	18900
a combination of formation of new connections	18932
a combination	18932
formation of new connections	18949
formation	18949
new connections	18962
sprouting and transfer	18981
function between pathways -LRB- Raineteau et al. , 2002 -RRB-	19007
function	19007
pathways -LRB- Raineteau et al. , 2002 -RRB-	19024
pathways	19024
Raineteau	19034
et al. , 2002	19044
et al.	19044
2002	19052
larger lesions	19077
there	19093
an element of function that is permanently lost	19118
an element	19118
function	19132
a patient	19182
an injury in which some functions are spared	19201
an injury	19201
some functions	19220
he	19247
severe and intractable disabilities	19273
the tracts that have been severed	19322
the tracts	19322
a unique type of information	19364
a unique type	19364
information	19381
the remaining tracts	19425
This model	19468
the obligatory relationship between the dorsal CST	19492
the obligatory relationship	19492
the dorsal CST	19528
a whole and DFR	19546
a whole	19546
DFR	19558
our results with incomplete lesions of the CST	19572
our results	19572
incomplete lesions of the CST	19589
incomplete lesions	19589
the CST	19611
the CST specificity	19640
partial lesions of the CST	19681
partial lesions	19681
the CST	19700
DFR	19709
a rate	19725
a degree , proportional to the number of spared CST fibers	19740
a degree	19740
proportional to the number of spared CST fibers	19750
proportional	19750
the number of spared CST fibers	19766
the number	19766
spared CST fibers	19780
This	19799
the CST	19818
specific subgroups of fibers dedicated to specific functions	19840
specific subgroups	19840
fibers dedicated to specific functions	19862
fibers	19862
specific functions	19882
The delayed return of DFR after incomplete CST lesions	19902
The delayed return	19902
DFR after incomplete CST lesions	19924
DFR	19924
incomplete CST lesions	19934
the surviving part of the CST	19995
the surviving part	19995
the CST	20017
functions	20054
even very small numbers of surviving fibers -LRB- Fig. 2H -RRB-	20069
even very small numbers	20069
surviving fibers	20096
Fig. 2H	20114
Restoration	20124
function by delayed transplants Recovery	20139
function	20139
delayed transplants Recovery	20151
ipsilateral DFR after complete unilateral CST lesions	20183
ipsilateral DFR	20183
complete unilateral CST lesions	20205
OECs	20254
the lesion site	20281
Transplants misplaced in the dorsal columns	20298
Transplants	20298
the dorsal columns	20323
only 1 -- 2 mmaway from the lesion site	20352
only 1	20352
2 mmaway from the lesion site	20359
2 mmaway	20359
the lesion site	20373
recovery of function -LRB- Fig. 5B -RRB-	20404
recovery	20404
function -LRB- Fig. 5B -RRB-	20416
function	20416
Fig. 5B	20426
we	20445
transplanted OECs migrating for up to 11 mm within the distal CST	20458
transplanted OECs	20458
up to 11 mm within the distal CST	20490
up to 11 mm	20490
11	20496
the distal CST	20509
their migratory ability	20525
tissue boundaries such as those between adjacent white matter tracts	20576
tissue boundaries	20576
those between adjacent white matter tracts	20602
those	20602
adjacent white matter tracts	20616
the cells	20663
direct contact	20691
the tract to be repaired	20711
Additional anatomical studies	20737
the mechanism	20795
the transplanted OECs	20818
return of function	20848
return	20848
function	20858
us	20872
one of the most attractive ideas	20876
one	20876
the most attractive ideas	20883
the functions	20917
regeneration of severed CST fibers	20947
regeneration	20947
severed CST fibers	20963
this and the previous study -LRB- Li et al. , 1997 -RRB-	20997
this	20997
the previous study -LRB- Li et al. , 1997 -RRB-	21006
the previous study	21006
Li	21026
et al. , 1997	21029
et al.	21029
1997	21037
we	21044
instances	21057
BD	21070
CST fibers	21095
the transplant	21115
the distal CST	21152
their normal destinations -LRB- Fig. 6B -- D -RRB-	21170
their normal destinations	21170
Fig. 6B -- D	21197
Fig. 6B	21197
D	21205
P0 staining	21209
these fibers	21232
number	21256
526 ± 58 myelinated fibers -LRB- Fig. 7B , C -RRB-	21264
526 ± 58 myelinated fibers	21264
526	21264
58 myelinated fibers	21268
Fig. 7B , C	21290
Fig. 7B	21290
C	21298
only 1 %	21311
the total number of ≈ 50,000 CST myelinated fibers -LRB- Li et al. , 1997 -RRB-	21322
the total number	21322
≈ 50,000 CST myelinated fibers -LRB- Li et al. , 1997 -RRB-	21342
≈ 50,000 CST myelinated fibers	21342
Li	21373
et al. , 1997	21376
et al.	21376
1997	21384
That such small numbers of fibers	21391
That such small numbers	21391
fibers	21418
useful return of function	21437
useful return	21437
function	21454
the observation	21484
untransplanted rats	21508
the lesions	21537
only 1 % of the CaM-II-positive CST fibers	21555
only 1 %	21555
the CaM-II-positive CST fibers	21566
Fig. 2H	21598
DFR	21608
It	21636
the terminal distribution of the regenerating fibers	21672
the terminal distribution	21672
the regenerating fibers	21701
the same area as normal	21733
the same area	21733
normal	21750
we	21758
no indication of the extent to which the cortical somatotopic map is restored	21766
no indication	21766
the extent to which the cortical somatotopic map is restored	21783
the extent	21783
the cortical somatotopic map	21803
fibers	21857
example to lumbar levels	21897
example	21897
lumbar levels	21908
It	21923
a possibility	21934
transplanted OECs	21953
recovery of function , at least	21982
recovery of function	21982
recovery	21982
function	21994
part	22016
stimulation of uncut fibers	22025
stimulation	22025
uncut fibers	22040
humoral mechanisms	22059
the intense vascularization	22104
the transplants or remyelination of undetected	22135
the transplants or remyelination	22135
fibers	22202
the mechanism	22224
the functional outcome	22239
only transplants bridging the lesion	22272
only transplants	22272
the lesion	22298
function	22329
terms of future human therapy	22342
terms	22342
future human therapy	22351
the encouraging aspects of the present findings	22373
the encouraging aspects	22373
the present findings	22400
that	22430
function	22447
transplants in situations	22470
transplants	22470
situations	22485
no spontaneous recovery	22505
the beneficial reparative effects of donorOECtransplants	22560
the beneficial reparative effects	22560
donorOECtransplants	22597
transplantation	22642
2 months	22673
the CST lesions	22688
rats	22707
